Inactive Instrument

PDL BioPharma, Inc.

Equities

PDLI

US69329Y1047

Biotechnology & Medical Research

Tranche Update on PDL BioPharma, Inc.'s Equity Buyback Plan announced on December 9, 2019.

March 29, 2021 at 10:19 am EDT

From October 1, 2020 to December 31, 2020, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 15,532,000 shares, representing 12.91% for $50.39 million under the buyback announced on December 9, 2019.

Latest news about PDL BioPharma, Inc.

PDL BioPharma, Inc.'s Equity Buyback announced on December 9, 2019 has expired with the repurchase of 15,532,000 shares, representing 12.91% for $50.39 million.	21-12-30	CI
Tranche Update on PDL BioPharma, Inc.'s Equity Buyback Plan announced on December 9, 2019.	21-03-29	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from S&P Global BMI Index	21-01-05	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from S&P TMI Index	21-01-05	CI
PDL BioPharma, Inc.(NasdaqGM:PDLI) dropped from NASDAQ Biotechnology Index	21-01-01	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 2000 Dynamic Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 2000 Value-Defensive Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 2000 Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 3000 Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 2500 Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 2000 Value Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell Small Cap Completeness Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell Small Cap Comp Value Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 2500 Value Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 3000 Value Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell Microcap Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 3000E Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 3000E Value Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell Microcap Value Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 2000 Defensive Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 2500 Defensive Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 2500 Dynamic Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 2000 Value-Dynamic Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 2500 Value-Defensive Index	20-12-30	CI
PDL BioPharma, Inc.(NasdaqGS:PDLI) dropped from Russell 2500 Value-Dynamic Index	20-12-30	CI

Chart PDL BioPharma, Inc.

Duration

Period

More charts

Company Profile

PDL BioPharma, Inc. has a portfolio of income generating assets based on alternative financings. These alternative financings fall into one of three categories: royalty monetization, debt structures and hybrids of the two. The Company's investments are typically in assets with strong intellectual property protection and are commercial stage or soon-to-be approved. The counterparties in these transactions can be biotechs, pharmas, medtech companies, universities and inventors.

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	+1.77%	42.75B
LONZA GROUP AG	+47.70%	41.61B
MODERNA, INC.	+12.24%	41.34B
CELLTRION, INC.	-8.83%	26.59B
ICON PUBLIC LIMITED COMPANY	+7.44%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-23.01%	18.12B
MEDPACE HOLDINGS, INC.	+30.56%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.82%	11.76B
UNITED THERAPEUTICS CORPORATION	+8.35%	11B

Other Biotechnology & Medical Research